Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus-Philipp Maier

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 18, 2020
Treatment of graft versus host disease with methotrexate after allogeneic hematopoietic stem cell transplantationBenjamin Walz, Claus-Philipp Maier, Volker Beck, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 25, 2021
Benjamin Walz, Claus-Philipp Maier, Volker Beck, et al.
Expert Review of Clinical Immunology|October 11, 2022
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimensRupert Handgretinger, Anne-Marie Arendt, Claus-Philipp Maier, et al.
Bone Marrow Transplantation|February 26, 2025
Long-term patient-reported outcomes following allogeneic hematopoietic cell transplantationSina Alexandra Beer, Johanna Blättel, Kristina Reuß, et al.
Frontiers in Immunology|November 17, 2025
Case Report: A neoantigen-targeting peptide vaccine combined with checkpoint inhibition induces tumor regression and long-term remission in a pediatric patient with metastatic hepatocellular carcinomaGermano Amorelli, Armin Rabsteyn, Claus-Philipp Maier, et al.
Cytotherapy|June 21, 2024
Immune reconstitution after transplantation of autologous peripheral stem cells in children: a comparison between CD34+ selected and nonmanipulated graftsTim Flaadt, Christina Jaki, Claus-Philipp Maier, et al.
Frontiers in Immunology|January 2, 2025
SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapyIoana Martac, Sina A Beer, Aileen Schenk, et al.
Transplantation and Cellular Therapy|March 17, 2022
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study GroupJudith Schaffrath, Christina Brummer, Daniel Wolff, et al.
Blood Advances|January 30, 2024
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCTClaus-Philipp Maier, Chihab Klose, Christian Martin Seitz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 18, 2020
Treatment of graft versus host disease with methotrexate after allogeneic hematopoietic stem cell transplantationBenjamin Walz, Claus-Philipp Maier, Volker Beck, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 25, 2021
Benjamin Walz, Claus-Philipp Maier, Volker Beck, et al.
Expert Review of Clinical Immunology|October 11, 2022
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimensRupert Handgretinger, Anne-Marie Arendt, Claus-Philipp Maier, et al.
Bone Marrow Transplantation|February 26, 2025
Long-term patient-reported outcomes following allogeneic hematopoietic cell transplantationSina Alexandra Beer, Johanna Blättel, Kristina Reuß, et al.
Frontiers in Immunology|November 17, 2025
Case Report: A neoantigen-targeting peptide vaccine combined with checkpoint inhibition induces tumor regression and long-term remission in a pediatric patient with metastatic hepatocellular carcinomaGermano Amorelli, Armin Rabsteyn, Claus-Philipp Maier, et al.
Cytotherapy|June 21, 2024
Immune reconstitution after transplantation of autologous peripheral stem cells in children: a comparison between CD34+ selected and nonmanipulated graftsTim Flaadt, Christina Jaki, Claus-Philipp Maier, et al.
Frontiers in Immunology|January 2, 2025
SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapyIoana Martac, Sina A Beer, Aileen Schenk, et al.
Transplantation and Cellular Therapy|March 17, 2022
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study GroupJudith Schaffrath, Christina Brummer, Daniel Wolff, et al.
Blood Advances|January 30, 2024
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCTClaus-Philipp Maier, Chihab Klose, Christian Martin Seitz, et al.
Pageof 1